-
LONGITUDINAL ANALYSIS OF EOSINOPHILIC ESOPHAGITIS IN CLAIMS DATA BEFORE THE INTRODUCTION OF A SPECIFIC ICD-10-GM-CODE
Aug 11, 2026, 17:15 PM -
ADHERENCE TO THE ISPOR GLOBAL PHARMACOECONOMIC MODEL ADAPTATION GUIDANCE: A REVIEW OF PUBLISHED ECONOMIC MODEL ADAPTATIONS
Aug 11, 2026, 17:15 PM -
ECONOMIC RWD AND MCDA VALUE ASSESSMENT OF PERIPHERALLY INSERTED CENTRAL CATHETER (PICC) USE VERSUS CENTRALLY INSERTED CENTRAL CATHETER (CICC) IN HIGH-COMPLEXITY PATIENTS IN BRAZIL. AN HOSPITAL-PERSPECTIVE ECONOMIC MODEL ANALYSIS
Aug 11, 2026, 17:15 PM -
REAL-WORLD EFFECTIVENESS OF EMICIZUMAB PROPHYLAXIS IN PATIENTS WITH HEMOPHILIA A: A FIRST NATIONWIDE REPORT FROM SOUTH KOREA
Aug 11, 2026, 17:15 PM -
THE TIME AND COST BURDEN OF NURSE DOCUMENTATION IN HOSPITAL INFORMATION SYSTEMS: A POLISH SURVEY WITH NATIONAL COST EXTRAPOLATION
Aug 11, 2026, 17:15 PM -
IMPACT OF PATIENT INVOLVEMENT IN TREATMENT DECISION-MAKING ON HEALTH-RELATED QUALITY OF LIFE (HRQOL) IN METASTATIC UROTHELIAL CANCER (MUC): RESULTS OF A CROSS-SECTIONAL, REAL-WORLD SURVEY IN EUROPE AND THE US
Aug 11, 2026, 17:15 PM -
A STRUCTURED FRAMEWORK FOR EVIDENCE PRIORITIZATION TO SUPPORT SYSTEMATIC LITERATURE REVIEW AND INDIRECT TREATMENT COMPARISON IN JOINT CLINICAL ASSESSMENTS: APPLICATION IN ALK-POSITIVE NON-SMALL CELL LUNG CANCER
Aug 11, 2026, 17:15 PM -
TRIMESTER-SPECIFIC MATERNAL ERYTHROCYTE INDICES AS PREDICTORS OF ADVERSE NEONATAL OUTCOMES: A CROSS-SECTIONAL STUDYFROMA HIGH-BURDEN LMIC SETTING
Aug 11, 2026, 17:15 PM -
EVALUATING THE TRANSPORTABILITY OF NON-INFERIORITY EVIDENCE FOR CHEMOTHERAPHY DE-ESCALATION IN N+ HR+HER2- BREAST CANCER: A HTA SIMULATION STUDY
Aug 11, 2026, 17:15 PM -
VALIDATING GENERATIVE AI-ASSISTED SYSTEMATIC LITERATURE REVIEW WORKFLOWS IN HEOR: ACCURACY, EFFICIENCY, AND GOVERNANCE IMPLICATIONS
Aug 11, 2026, 17:15 PM -
CHANGES IN THE NUMBER OF PREGNANCY AND LACTATION POST-MARKETING REQUIREMENTS/COMMITMENTS ISSUED BY THE FDA AFTER THE RELEASE OF THE DRAFT POSTAPPROVAL PREGNANCY SAFETY STUDIES GUIDELINES IN 2019
Aug 11, 2026, 17:15 PM -
COMPARATOR SELECTION IN JAPAN'S HTA SYSTEM: FROM GUIDELINE PRINCIPLES TO PRACTICE, AND COMPARISON WITH INTERNATIONAL HTA AGENCIES
Aug 11, 2026, 17:15 PM -
ACCESS TO MODERN THERAPIES FOR PROSTATE CANCER PATIENTS IN CENTRAL AND EASTERN EUROPE (CEE): A CROSS-COUNTRY ASSESSMENT OF HTA AND REIMBURSEMENT PATHWAYS
Aug 11, 2026, 17:15 PM -
ECONOMIC VALUE OF PHARMACY AUTOMATION IN HOSPITALS: AN UPDATED SYSTEMATIC REVIEW
Aug 11, 2026, 17:15 PM -
COST-EFFECTIVENESS ANALYSIS OF SINGLE-INHALER EXTRAFINE BECLOMETHASONE/FORMOTEROL/GLYCOPYRRONIUM BROMIDE FOR ADULT PATIENTS WITH UNCONTROLLED ASTHMA FROM THE BRAZILIAN PUBLIC HEALTHCARE SYSTEM PERSPECTIVE
Aug 11, 2026, 17:15 PM -
SYSTEMATIC EVALUATION OF CLINICAL DATA MODEL COVERAGE AND ALIGNMENT WITH ESMO PRECISION ONCOLOGY MOLECULAR TUMOUR BOARD RECOMMENDATIONS
Aug 11, 2026, 17:15 PM -
THE HIDDEN IMPACT OF CONFIDENTIAL REBATES ON HEALTH TECHNOLOGY ASSESSMENT: A COST-EFFECTIVENESS CASE STUDY IN TAIWAN
Aug 11, 2026, 17:15 PM -
GOVERNANCE AND PRIORITIZATION FRAMEWORKS FOR EQUITABLE ACCESS TO INNOVATIVE HEALTH TECHNOLOGIES IN THE MENA REGION: A CONSENSUS-DRIVEN APPROACH
Aug 11, 2026, 17:15 PM -
MAPPING PATIENT EXPERIENCES WITH GLP-1 RECEPTOR AGONISTS TO THE EQ-5D-5L FRAMEWORK USING ONLINE COMMUNITY FORUMS
Aug 11, 2026, 17:15 PM -
BUILDING TRUST: TRANSPARENCY AND STAKEHOLDER PARTICIPATION IN EU HTA
Aug 11, 2026, 17:15 PM
